ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 306 out of 4623

$766K Total Retail Price of All Prescriptions

Rank: 296 out of 4623

855 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 855 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 8,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
PRAVASTATIN SODIUM 657 484 1 11
LEVOTHYROXINE SODIUM 634 463 2 1
AMLODIPINE BESYLATE 316 268 3 5
BENAZEPRIL HCL 295 225 4 70
METFORMIN HCL 291 157 5 6
LISINOPRIL 285 188 6 4
HYDROCODONE-ACETAMINOPHEN 265 180 S3 7 3
GLYBURIDE-METFORMIN HCL 249 134 R 8 56
OMEPRAZOLE 249 167 8 7
ATORVASTATIN CALCIUM 246 202 10 12
BENAZEPRIL-HYDROCHLOROTHIAZIDE 237 185 11 212
NEXIUM 210 138 12 17
FUROSEMIDE 202 116 13 8
CRESTOR 197 120 14 20
GABAPENTIN 177 62 15 16
POTASSIUM CHLORIDE 176 108 16 14
METOPROLOL TARTRATE 174 110 17 9
MELOXICAM 170 121 18 27
TRAMADOL HCL 166 86 19 15
METOPROLOL SUCCINATE 161 140 20 13
CLOPIDOGREL 156 123 21 31
CITALOPRAM HBR 152 113 22 23
HYDROCHLOROTHIAZIDE 147 120 23 10
LOSARTAN POTASSIUM 134 130 24 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 50 25 19
GLYBURIDE 119 97 R 26 59
SIMVASTATIN 118 61 27 2
AZITHROMYCIN 118 78 27 33
NAPROXEN 115 72 29 63
JANUVIA 113 58 30 52
ISOSORBIDE MONONITRATE ER 111 93 31 60
PROAIR HFA 108 54 32 64
ALENDRONATE SODIUM 95 87 33 22
LOVASTATIN 88 66 34 34
FAMOTIDINE 88 67 34 82
ZETIA 87 38 36 92
ATENOLOL 87 74 36 28
CYCLOBENZAPRINE HCL 83 29 R 38 53
CIPROFLOXACIN HCL 83 59 38 43
CYMBALTA 82 33 40 48
LOSARTAN-HYDROCHLOROTHIAZIDE 82 61 40 46
ENALAPRIL MALEATE 82 36 40 41
GLIPIZIDE 79 49 43 49
SYMBICORT 79 51 43 151
VERAPAMIL ER 77 70 45 96
PLAVIX 76 60 46 45
PAROXETINE HCL 75 47 47 78
ZOLPIDEM TARTRATE 74 51 48 18
PANTOPRAZOLE SODIUM 70 51 49 35
METFORMIN HCL ER 70 43 49 51
BYSTOLIC 68 48 51 115
RANITIDINE HCL 65 40 52 47
DIOVAN 64 53 53 39
DIGOXIN 64 40 53 58
ALLOPURINOL 63 53 55 37
SINGULAIR 62 35 56 83
CLONIDINE HCL 61 33 57 40
TRICOR 60 35 58 88
LEVEMIR FLEXPEN 58 32 59 167
GEMFIBROZIL 57 37 60 94
DICLOFENAC SODIUM 57 32 60 121
AMLODIPINE BESYLATE-BENAZEPRIL 54 39 62 55
LOVAZA 54 39 62 112
ESCITALOPRAM OXALATE 53 37 64 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 29 65 68
HYDROXYZINE HCL 50 28 R 66 138
LIPITOR 50 38 66 100
VESICARE 50 37 66 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.